JP2014074012A5 - - Google Patents

Download PDF

Info

Publication number
JP2014074012A5
JP2014074012A5 JP2013176862A JP2013176862A JP2014074012A5 JP 2014074012 A5 JP2014074012 A5 JP 2014074012A5 JP 2013176862 A JP2013176862 A JP 2013176862A JP 2013176862 A JP2013176862 A JP 2013176862A JP 2014074012 A5 JP2014074012 A5 JP 2014074012A5
Authority
JP
Japan
Prior art keywords
derivatives
salts
alcohol
pyrrolidone
poe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013176862A
Other languages
English (en)
Japanese (ja)
Other versions
JP5686874B2 (ja
JP2014074012A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013176862A priority Critical patent/JP5686874B2/ja
Priority claimed from JP2013176862A external-priority patent/JP5686874B2/ja
Publication of JP2014074012A publication Critical patent/JP2014074012A/ja
Publication of JP2014074012A5 publication Critical patent/JP2014074012A5/ja
Application granted granted Critical
Publication of JP5686874B2 publication Critical patent/JP5686874B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013176862A 2012-09-14 2013-08-28 医薬組成物 Expired - Fee Related JP5686874B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013176862A JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012203293 2012-09-14
JP2012203293 2012-09-14
JP2013176862A JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014056829A Division JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Publications (3)

Publication Number Publication Date
JP2014074012A JP2014074012A (ja) 2014-04-24
JP2014074012A5 true JP2014074012A5 (enExample) 2014-06-05
JP5686874B2 JP5686874B2 (ja) 2015-03-18

Family

ID=49226452

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013176862A Expired - Fee Related JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物
JP2014056829A Expired - Fee Related JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014056829A Expired - Fee Related JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Country Status (7)

Country Link
US (1) US20150238606A1 (enExample)
EP (1) EP2895164A1 (enExample)
JP (2) JP5686874B2 (enExample)
CN (1) CN104619320A (enExample)
IN (1) IN2015DN02377A (enExample)
RU (1) RU2621615C2 (enExample)
WO (1) WO2014042043A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
CN104619703A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物
JP5460797B1 (ja) * 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
IN2015DN02929A (enExample) 2012-09-14 2015-09-18 Pola Pharma Inc
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6503627B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬液体組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6242655B2 (ja) * 2013-10-29 2017-12-06 リンテック株式会社 機能性物質の放出方法、機能性物質の放出用キット及び放出性組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2017203456A1 (en) * 2016-05-25 2017-11-30 Glenmark Pharmaceuticals Limited Luliconazole stable topicalcompositions
CN107865825B (zh) * 2016-09-28 2022-05-20 四川海思科制药有限公司 一种卢立康唑外用喷雾剂药物组合物及其制备方法
WO2018179170A1 (ja) * 2017-03-29 2018-10-04 日本農薬株式会社 感染症を治療するための医薬組成物
SG11202003820VA (en) * 2017-10-30 2020-05-28 Kaken Pharmaceutical Co Ltd External preparation for treating trichophytosis unguium
CN108143711A (zh) * 2018-01-13 2018-06-12 天津双硕医药科技有限公司 一种含有卢立康唑的外用乳膏组合物
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
CN113774390B (zh) * 2021-08-12 2023-08-04 上海新阳半导体材料股份有限公司 一种用于化学机械抛光后的清洗液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006339842B2 (en) * 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
WO2007102243A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
US8492421B2 (en) * 2007-08-27 2013-07-23 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis
WO2009031642A1 (ja) * 2007-09-05 2009-03-12 Pola Pharma Inc. 医薬組成物
EP2191828B1 (en) 2007-09-05 2016-08-10 Pola Pharma Inc. Antifungal pharmaceutical composition
JP5345937B2 (ja) * 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
US20090130232A1 (en) * 2007-11-20 2009-05-21 Mohammed Zahra Composition and method for treatment of oral inflammation an ulceration
US8445717B2 (en) * 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
EP2395839B1 (en) * 2009-02-13 2014-05-07 Topica Pharmaceuticals, Inc Anti-fungal formulation
EP2416758B8 (en) * 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) * 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8952044B2 (en) * 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) * 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2675441A4 (en) * 2011-02-17 2014-12-31 Chd Bioscience Inc COMPOSITIONS WITH PEROXY-ALPHA-KETOCARBOXYLIC ACID AND METHOD FOR THE PRODUCTION AND THEIR USE

Similar Documents

Publication Publication Date Title
JP2014074012A5 (enExample)
JP2014111672A5 (enExample)
RU2015108930A (ru) Фармацевтическая композиция, содержащая луликоназол
JP2012523410A5 (enExample)
JP2018534912A5 (enExample)
JP2010521442A5 (enExample)
WO2013126990A8 (en) Method for the preparation of triglycerides of medium-chain length fatty acids
FR2948568A1 (fr) Formulation pharmaceutique
JP2014509655A5 (enExample)
JP2013528157A5 (enExample)
JP2017510634A5 (enExample)
JP2014505017A5 (enExample)
JP2012531470A5 (enExample)
RU2016137349A (ru) Успокоительный феромон для кошек
RU2017118733A (ru) Фармацевтическая композиция для перорального приема, содержащая таксан
MX2019001584A (es) Mezclas que comprenden (e)-3-benzo[1,3]dioxol-5-il-n,n-difenil-2-p ropenamida.
JP2018515463A5 (enExample)
JP2017514001A5 (enExample)
JPWO2020141180A5 (enExample)
JP2011219410A5 (enExample)
JP2012528801A5 (enExample)
JP6900189B2 (ja) 外用組成物
JP2013529686A5 (enExample)
MX2017005080A (es) Preparacion de citrato de zinc y composiciones para cuidado oral que contienen citrato de zinc.
JP2014533694A5 (enExample)